[ad_1]

The vaccine candidate developed by Jenner Institute of the Oxford University has been making headlines recently, all thanks to media reports and sources claiming that the vaccine candidate has been successful in its early trials. Infact, encouraging media reports regarding the success of the Oxford vaccine candidate in the preliminary trials have been doing rounds since Wednesday.

However, the part of the development which has given rise to new hopes, are the reports that the AstraZeneca-backed vaccine candidate might be able to provide ‘double protection’ against the highly infectious coronavirus.

[ad_2]

Source link